Literature DB >> 1356184

Stress failure of pulmonary capillaries: role in lung and heart disease.

J B West1, O Mathieu-Costello.   

Abstract

Pulmonary capillaries have extremely thin walls to allow rapid exchange of respiratory gases across them. Recently it has been shown that the wall stresses become very large when the capillary pressure is raised, and in anaesthetised rabbits, ultrastructural damage to the walls is seen at pressures of 40 mm Hg and above. The changes include breaks in the capillary endothelial layer, alveolar epithelial layer, and sometimes all layers of the wall. The strength of the thin part of the capillary wall can be attributed to the type IV collagen in the extracellular matrix. Stress failure of pulmonary capillaries results in a high-permeability form of oedema, or even frank haemorrhage, and is apparently the mechanism of neurogenic pulmonary oedema and high-altitude pulmonary oedema. It also explains the exercise-induced pulmonary haemorrhage that occurs in all racehorses. Several features of mitral stenosis are consistent with stress failure. Overinflation of the lung also leads to stress failure, a common cause of increased capillary permeability in the intensive care environment. Stress failure also occurs if the type IV collagen of the capillary wall is weakened by autoantibodies as in Goodpasture's syndrome. Neutrophil elastase degrades type IV collagen and this may be the starting point of the breakdown of alveolar walls that is characteristic of emphysema. Stress failure of pulmonary capillaries is a hitherto overlooked and potentially important factor in lung and heart disease.

Entities:  

Keywords:  NASA Discipline Cardiopulmonary; Non-NASA Center

Mesh:

Year:  1992        PMID: 1356184     DOI: 10.1016/0140-6736(92)92301-u

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  32 in total

1.  Hemoptysis due to breath-hold diving following chemotherapy and lung irradiation.

Authors:  Markus Gutsche; Ware G Kuschner
Journal:  Clin Med Res       Date:  2012-04-25

2.  Pulmonary oedema and haemoptysis induced by strenuous swimming.

Authors:  D Weiler-Ravell; A Shupak; I Goldenberg; P Halpern; O Shoshani; G Hirschhorn; A Margulis
Journal:  BMJ       Date:  1995-08-05

Review 3.  Determinants and control of breathing during muscular exercise.

Authors:  B J Whipp; S A Ward
Journal:  Br J Sports Med       Date:  1998-09       Impact factor: 13.800

4.  Neurogenic pulmonary oedema.

Authors:  G W Kerr
Journal:  J Accid Emerg Med       Date:  1998-07

5.  A cell-molecular approach predicts vertebrate evolution.

Authors:  John Steven Torday; Virender Kumar Rehan
Journal:  Mol Biol Evol       Date:  2011-05-18       Impact factor: 16.240

6.  Heart or lung failure: what causes exertional, high altitude, and cold immersion pulmonary oedema?

Authors:  Dan Tunstall Pedoe
Journal:  Br J Sports Med       Date:  1995-12       Impact factor: 13.800

Review 7.  Comorbidity of heart failure and chronic obstructive pulmonary disease: more than coincidence.

Authors:  Gülmisal Güder; Frans H Rutten
Journal:  Curr Heart Fail Rep       Date:  2014-09

Review 8.  Bioengineering the Blood-gas Barrier.

Authors:  Katherine L Leiby; Micha Sam Brickman Raredon; Laura E Niklason
Journal:  Compr Physiol       Date:  2020-03-12       Impact factor: 9.090

9.  A transgenic mouse with vascular endothelial over-expression of the non-muscle myosin light chain kinase-2 isoform is susceptible to inflammatory lung injury: role of sexual dimorphism and age.

Authors:  Jaideep Moitra; Carrie Evenoski; Saad Sammani; Raj Wadgaonkar; Jerrold R Turner; Shwu Fan Ma; Joe G N Garcia
Journal:  Transl Res       Date:  2008-01-18       Impact factor: 7.012

10.  Cyclic tensile strain triggers a sequence of autocrine and paracrine signaling to regulate angiogenic sprouting in human vascular cells.

Authors:  Yu Ching Yung; Jeiwook Chae; Markus J Buehler; Craig P Hunter; David J Mooney
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.